Decoding Ozempic & Rewriting Obesity Care (ft. author Dr. Alexandra Sowa)

FUTUREPROOF.

Send us a text

In this episode, we dive into the world of obesity treatment with Dr. Alexandra Sowa, author of The Ozempic Revolution and a trailblazer in the field of obesity medicine. We explore the revolutionary impact of GLP-1 medications like Ozempic and Wegovy, which are transforming the approach to obesity—a condition affecting nearly half of Americans.

What You'll Learn:

• The science behind GLP-1 medications and how they work to combat obesity.
• Eligibility criteria for these medications and how to access them.
• Addressing common misconceptions and misinformation surrounding GLP-1s.
• Practical strategies for managing side effects and optimizing treatment outcomes.
• The importance of holistic approaches in treating obesity, beyond medication.

About our Guest: Dr. Alexandra Sowa, an expert in internal medicine and obesity medicine, clinical instructor at NYU School of Medicine, and a prominent voice in public discussions on obesity.

Topics Covered:

1. The Role of GLP-1 Medications: Understanding their mechanism and who benefits the most.
2. Navigating Access and Insurance: Tips on prescription accessibility and insurance coverage.
3. Combating Misinformation: Debunking myths and clarifying what users can really expect.
4. Lifestyle Integration: How to incorporate these medications into a holistic health regimen.
5. Emotional and Psychological Considerations: Handling the mental challenges associated with dramatic weight loss.
6. Future of Obesity Treatment: Insights into upcoming advancements and what the next decade could hold.